Determinants of Work Disability in Patients with Systemic Sclerosis: A Longitudinal Study of the GENISOS Cohort

Seminars in Arthritis and Rheumatism

Volumn 41, Issue 1, 2011, Pages 38-47

  Sharif, Roozbeh ^a   Mayes, Maureen D ^a   Nicassio, Perry M ^b   Gonzalez, Emilio B ^c   Draeger, Hilda ^d   McNearney, Terry A ^c   Estrada Y Martin, Rosa M ^e   Nair, Deepthi K ^a   Reveille, John D ^a   Arnett, Frank C ^a   Assassi, Shervin ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^e UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Fatigue; ISEL; Medsger Lung Severity Index; SF 36; Systemic sclerosis; Work disability

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FATIGUE SEVERITY SCORE; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; LUNG DIFFUSION CAPACITY; MAJOR CLINICAL STUDY; MALE; MEDSGER LUNG SEVERITY INDEX; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SOCIAL SUPPORT; SYSTEMIC SCLEROSIS; WORK DISABILITY;

DISABLED PERSONS; EMPLOYMENT; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PSYCHOLOGY; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; TEXAS; WORK CAPACITY EVALUATION;

EID: 80051470239     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2011.01.002     Document Type: Article

References (54)

1. Steen V.D. Clinical manifestations of systemic sclerosis. Semin Cutan Med Surg 1998, 17(1):48-54.
2. Ioannidis J.P., Vlachoyiannopoulos P.G., Haidich A.B., Medsger T.A., Lucas M., Michet C.J., et al. Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118(1):2-10.
3. Assassi S., Del J.D., Sutter K., McNearney T.A., Reveille J.D., Karnavas A., et al. Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009, 61(10):1403-1411.
4. Ferri C., Valentini G., Cozzi F., Sebastiani M., Michelassi C., La M.G., et al. Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002, 81(2):139-153.
5. Scussel-Lonzetti L., Joyal F., Raynauld J.P., Roussin A., Rich E., Goulet J.R., et al. Predicting mortality in systemic sclerosis: analysis of a cohort of 309 French Canadian patients with emphasis on features at diagnosis as predictive factors for survival. Medicine (Baltimore) 2002, 81(2):154-167.
6. Khanna D., Ahmed M., Furst D.E., Ginsburg S.S., Park G.S., Hornung R., et al. Health values of patients with systemic sclerosis. Arthritis Rheum 2007, 57(1):86-93.
7. Hudson M., Steele R., Lu Y., Thombs B.D., Baron M. Work disability in systemic sclerosis. J Rheumatol 2009, 36(11):2481-2486.
8. Nguyen C., Poiraudeau S., Mestre-Stanislas C., Rannou F., Berezne A., Papelard A., et al. Employment status and socio-economic burden in systemic sclerosis: a cross-sectional survey. Rheumatology (Oxford) 2009, 49(5):982-989.
9. Berezne A., Seror R., Morell-Dubois S., De M.M., Fois E., Dzeing-Ella A., et al. Impact of systemic sclerosis on occupational and professional activity with attention to patients with digital ulcers. Arthritis Care Res (Hoboken) 2010, [epub ahead of print].
10. Ouimet J.M., Pope J.E., Gutmanis I., Koval J. Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J 2008, 2:44-52.
11. Sandqvist G., Scheja A., Eklund M. Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatology (Oxford) 2008, 47(11):1708-1711.
12. Suarez-Almazor M.E., Kallen M.A., Roundtree A.K., Mayes M. Disease and symptom burden in systemic sclerosis: a patient perspective. J Rheumatol 2007, 34(8):1718-1726.
13. Yelin E.H., Felts W.R. A summary of the impact of musculoskeletal conditions in the United States. Arthritis Rheum 1990, 33(5):750-755.
14. Cisternas M.G., Murphy L.B., Yelin E.H., Foreman A.J., Pasta D.J., Helmick C.G. Trends in medical care expenditures of US adults with arthritis and other rheumatic conditions 1997 to 2005. J Rheumatol 2009, 36(11):2531-2538.
15. Allaire S.H. Update on work disability in rheumatic diseases. Curr Opin Rheumatol 2001, 13(2):93-98.
16. Sokka T., Kautiainen H., Pincus T., Verstappen S.M., Aggarwal A., Alten R., et al. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 2010, 12(2):R42.
17. Bertoli A.M., Fernandez M., Alarcon G.S., Vila L.M., Reveille J.D. Systemic lupus erythematosus in a multiethnic US cohort LUMINA (XLI): factors predictive of self-reported work disability. Ann Rheum Dis 2007, 66(1):12-17.
18. Yazdany J., Yelin E. Health-related quality of life and employment among persons with systemic lupus erythematosus. Rheum Dis Clin North Am 2010, 36(1):15-32. vii.
19. Odegard S., Finset A., Kvien T.K., Mowinckel P., Uhlig T. Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol 2005, 34(6):441-447.
20. Ward M.M., Reveille J.D., Learch T.J., Davis J.C., Weisman M.H. Impact of ankylosing spondylitis on work and family life: comparisons with the US population. Arthritis Rheum 2008, 59(4):497-503.
21. Sandqvist G., Scheja A., Hesselstrand R. Pain, fatigue and hand function closely correlated to work ability and employment status in systemic sclerosis. Rheumatology (Oxford) 2010, 49(9):1739-1746.
22. Assassi S., Sharif R., Lasky R.E., McNearney T.A., Estrada Y.M.R., Draeger H., et al. Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort. Arthritis Res Ther 2010, 12(5):R166.
23. McNearney T.A., Reveille J.D., Fischbach M., Friedman A.W., Lisse J.R., Goel N., et al. Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007, 57(2):318-326.
24. McNearney T.A., Hunnicutt S.E., Fischbach M., Friedman A.W., Aguilar M., Ahn C.W., et al. Perceived functioning has ethnic-specific associations in systemic sclerosis: another dimension of personalized medicine. J Rheumatol 2009, 36(12):2724-2732.
25. Reveille J.D., Fischbach M., McNearney T., Friedman A.W., Aguilar M.B., Lisse J., et al. Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001, 30(5):332-346.
26. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23(5):581-590.
27. Dictionary of Occupational Titles 1991, Vol. 1. United States Department of Commerce. 4th ed.
28. Dictionary of Occupational Titles 1991, Vol. 2. United States Department of Commerce. 4th ed.
29. Leroy E.C., Black C., Fleischmajer R., Jablonska S., Krieg T., Medsger T.A., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15(2):202-205.
30. Clements P., Lachenbruch P., Siebold J., White B., Weiner S., Martin R., et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995, 22(7):1281-1285.
31. Medsger T.A., Silman A.J., Steen V.D., Black C.M., Akesson A., Bacon P.A., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999, 26(10):2159-2167.
32. Macintyre N., Crapo R.O., Viegi G., Johnson D.C., van der Grinten C.P., Brusasco V., et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26(4):720-735.
33. Wanger J., Clausen J.L., Coates A., Pedersen O.F., Brusasco V., Burgos F., et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005, 26(3):511-522.
34. Schwartz J.E., Jandorf L., Krupp L.B. The measurement of fatigue: a new instrument. J Psychosom Res 1993, 37(7):753-762.
35. Cohen S., Mermelstein R., Kamarck T., Hoberman H. Measuring the functional components of social support. Social support: theory, research, and applications 1985, 73-94. Martinus Nijhoff, Boston (MA). I. Sarason, B. Sarason (Eds.).
36. Pilowsky L., Spence N. Illnes behaviour questionnaire (IBQ). Measures for clinical practice 1996, 182. Free Press, New York (NY). 3rd ed. K. Corcoran, J. Fischer (Eds.).
37. Engle E.W., Callahan L.F., Pincus T., Hochberg M.C. Learned helplessness in systemic lupus erythematosus: analysis using the Rheumatology Attitudes Index. Arthritis Rheum 1990, 33(2):281-286.
38. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483.
39. Danieli E., Airo P., Bettoni L., Cinquini M., Antonioli C.M., Cavazzana I., et al. Health-related quality of life measured by the Short Form 36 (SF-36) in systemic sclerosis: correlations with indexes of disease activity and severity, disability, and depressive symptoms. Clin Rheumatol 2005, 24(1):48-54.
40. Khanna D., Furst D.E., Clements P.J., Park G.S., Hays R.D., Yoon J., et al. Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial. J Rheumatol 2005, 32(5):832-840.
41. Poole J.L., Williams C.A., Bloch D.A., Hollak B., Spitz P. Concurrent validity of the Health Assessment Questionnaire Disability Index in scleroderma. Arthritis Care Res 1995, 8(3):189-193.
42. Eberhardt K., Larsson B.M., Nived K., Lindqvist E. Work disability in rheumatoid arthritis-development over 15 years and evaluation of predictive factors over time. J Rheumatol 2007, 34(3):481-487.
43. Scofield L., Reinlib L., Alarcon G.S., Cooper G.S. Employment and disability issues in systemic lupus erythematosus: a review. Arthritis Rheum 2008, 59(10):1475-1479.
44. Sanchez M.L., McGwin G., Duran S., Fernandez M., Reveille J.D., Vila L.M., et al. Factors predictive of overall health over the course of the disease in patients with systemic lupus erythematosus from the LUMINA cohort (LXII): use of the SF-6D. Clin Exp Rheumatol 2009, 27(1):67-71.
45. Alarcon G.S., Calvo-Alen J., McGwin G., Uribe A.G., Toloza S.M., Roseman J.M., et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis 2006, 65(9):1168-1174.
46. Lachman M.E., Agrigoroaei S. Promoting functional health in midlife and old age: long-term protective effects of control beliefs, social support, and physical exercise. PLoS One 2010, 5(10):e13297.
47. Nietert P.J., Silver R.M., Mitchell H.C., Shaftman S.R., Tilley B.C. Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol 2005, 32(10):1888-1892.
48. Krishnan E., Furst D.E. Systemic sclerosis mortality in the United States: 1979-1998. Eur J Epidemiol 2005, 20(10):855-861.
49. Lurie N., Dubowitz T. Health disparities and access to health. JAMA 2007, 297(10):1118-1121.
50. Baker K., Pope J. Employment and work disability in systemic lupus erythematosus: a systematic review. Rheumatology (Oxford) 2009, 48(3):281-284.
51. Steen V.D., Medsger T.A. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007, 66(7):940-944.
52. Tashkin D.P., Elashoff R., Clements P.J., Goldin J., Roth M.D., Furst D.E., et al. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006, 354(25):2655-2666.
53. Sandusky S.B., McGuire L., Smith M.T., Wigley F.M., Haythornthwaite J.A. Fatigue: an overlooked determinant of physical function in scleroderma. Rheumatology (Oxford) 2009, 48(2):165-169.
54. Thombs B.D., Hudson M., Bassel M., Taillefer S.S., Baron M. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 2009, 61(7):966-973.